Interacting Drugs |
Daclizumab vs Sipuleucel-T |
Security Level |
 |
Mechanism |
Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T. |
Management |
Monitor therapy |
Daclizumab vs Sipuleucel-T
Post Review about Daclizumab vs Sipuleucel-T Click here to cancel reply.
Other Interactions of Daclizumab
Other Interactions of Sipuleucel-T
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.